Heart Test Laboratories I... (HSCS)
3.38
-0.18 (-5.06%)
At close: Mar 03, 2025, 3:53 PM
3.26
-3.55%
After-hours: Mar 03, 2025, 04:58 PM EST
No 1D chart data available
| Bid | 3.21 |
| Market Cap | 3.5M |
| Revenue (ttm) | 16.6 |
| Net Income (ttm) | -8.61K |
| EPS (ttm) | 5.35 |
| PE Ratio (ttm) | 0.63 |
| Forward PE | -0.49 |
| Analyst | Buy |
| Ask | 4 |
| Volume | 7,041 |
| Avg. Volume (20D) | 33,912 |
| Open | 3.42 |
| Previous Close | 3.56 |
| Day's Range | 3.35 - 3.47 |
| 52-Week Range | 2.36 - 18.50 |
| Beta | 2.90 |
About HSCS
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake...
Industry Medical - Devices
Sector Healthcare
IPO Date Jun 16, 2022
Employees 15
Stock Exchange NASDAQ
Ticker Symbol HSCS
Website https://heartsciences.com
Analyst Forecast
According to 2 analyst ratings, the average rating for HSCS stock is "Buy." The 12-month stock price forecast is $13.5, which is an increase of 299.41% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
9 months ago
-38.37%
Heart Test Laboratories shares are trading lower a...
Unlock content with
Pro Subscription
10 months ago
+9.1%
Heart Test Laboratories shares are trading higher after the company announced its European Patent Office Application EP3834729 has been granted.
